摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-Propan-2-yloxypent-1-yne | 2227549-60-0

中文名称
——
中文别名
——
英文名称
5-Propan-2-yloxypent-1-yne
英文别名
——
5-Propan-2-yloxypent-1-yne化学式
CAS
2227549-60-0
化学式
C8H14O
mdl
——
分子量
126.199
InChiKey
JZELPAJXJDZWGG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    9
  • 可旋转键数:
    4
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    重氮乙酸乙酯5-Propan-2-yloxypent-1-yne葡萄糖 、 cytochrome P411 variant V87W L437G T327V V328Y F216M T436H 作用下, 以 乙醇 为溶剂, 反应 12.0h, 以80%的产率得到ethyl (1R)-2-(3-propan-2-yloxypropyl)cycloprop-2-ene-1-carboxylate
    参考文献:
    名称:
    高应变碳环的酶促构建
    摘要:
    由血红素制成的双环 具有相邻三碳环(双环丁烷)的环状有机结构由于其极端的环应变,是化学和材料合成的有用起始材料。构建这些分子对有机化学家来说是一项具有挑战性的任务,尤其是在需要单一立体异构体的情况下。陈等人。设计了一种含血红素的酶,以使用炔底物催化连续的卡宾插入反应。从只能催化单个卡宾插入的酶开始,一系列突变导致变体催化高效、立体选择性地生产双环丁烷。通过使用反应性较低的炔烃底物并筛选更多具有活性位点突变的变体,作者发现了终止于中间体环丙烯的任一对映异构体的酶。科学,这个问题 p。71 一种工程化的含血红素酶催化不对称形成的张力双环丁烷和环丙烯。小碳环在结构上是刚性的,并且由于它们的环应变而具有高内能。这些特征导致了广泛的应用,但也给它们的构造带来了挑战。我们报告了通过连续卡宾加成到不饱和碳-碳键来催化手性双环丁烷形成的血红素蛋白工程,这是最紧张的四元系统之一。还鉴定了产生环丙烯(双环丁烷
    DOI:
    10.1126/science.aar4239
点击查看最新优质反应信息

文献信息

  • 4(1H)-QUINOLONE DERIVATIVES AND USES THEREOF
    申请人:Academia Sinica
    公开号:US20200330449A1
    公开(公告)日:2020-10-22
    Compounds of Formula (I) and methods for treating, delaying, and/or preventing the adverse effects of proliferative diseases, such as cancers including, for example, lung cancer, breast cancer, ovarian cancer, prostate cancer, head cancer, neck cancer, head and neck cancer, or leukemia (e.g., cancer resistant to treatment by one or more microtubule-targeting agents, e.g., cancer resistant to multiple drugs associated with P-glycoprotein (P-gp) overexpression). Methods of inhibiting polymerization of a cancer cell microtubule in a subject in need thereof or a cell, tissue, or biological sample, binding p-tubulin, inhibiting microtubule assembly and, inducing apoptosis in a cancer cell resistant to multiple drugs in a tissue, biological sample, or subject. Pharmaceutical compositions, kits, and methods of using the compounds for treating any of the target diseases described herein.
    公式(I)的化合物及治疗、延迟和/或预防增生性疾病的不良影响的方法,例如癌症,包括肺癌、乳腺癌、卵巢癌、前列腺癌、头颈癌、头颈癌或白血病(例如,对一种或多种微管靶向药物治疗耐药的癌症,例如对P-糖蛋白(P-gp)过表达相关的多种药物治疗耐药的癌症)。抑制癌细胞微管聚合的方法,适用于需要的个体或细胞、组织或生物样本,结合p-微管蛋白,抑制微管组装,并在组织、生物样本或个体中诱导对多种药物耐药的癌细胞的凋亡。药物组合物、试剂盒和使用上述化合物治疗任何本文描述的靶疾病的方法。
  • Biocatalytic synthesis of strained carbocycles
    申请人:California Institute of Technology
    公开号:US10829792B2
    公开(公告)日:2020-11-10
    Provided herein are methods for producing products containing strained carbocycles, such as cyclopropene moieties and/or bicyclobutane moieties. The methods include combining an alkyne and a carbene precursor in the presence of a heme protein, e.g., a cytochrome P450, under conditions sufficient to form the strained carbocycle. Reaction mixtures for producing strained carbocycles are also described, as well as whole-cell catalysts comprising heme proteins and variants thereof for forming cyclopropenes, bicyclobutanes, and related products.
    本文提供了生产含有受约束碳环(如环丙烯分子和/或双环丁烷分子)的产品的方法。这些方法包括在血红素蛋白(如细胞色素 P450)存在下,在足以形成受约束碳环的条件下,将炔烃和碳烯前体结合。此外,还描述了用于生产受约束碳环的反应混合物,以及包含血红素蛋白及其变体的全细胞催化剂,用于形成环丙烯、双环丁烷和相关产品。
  • SYNTHESIS OF HYBRID BLOCK COPOLYMERS AND USES THEREOF
    申请人:Breitenkamp Kurt
    公开号:US20110021718A1
    公开(公告)日:2011-01-27
    The present invention relates to the field of polymer chemistry and more particularly to multiblock copolymers and methods of preparing the same.
  • Biocatalytic Synthesis of Strained Carbocycles
    申请人:California Institute of Technology
    公开号:US20180305721A1
    公开(公告)日:2018-10-25
    Provided herein are methods for producing products containing strained carbocycles, such as cyclopropene moieties and/or bicyclobutane moieties. The methods include combining an alkyne and a carbene precursor in the presence of a heme protein, e.g., a cytochrome P450, under conditions sufficient to form the strained carbocycle. Reaction mixtures for producing strained carbocycles are also described, as well as whole-cell catalysts comprising heme proteins and variants thereof for forming cyclopropenes, bicyclobutanes, and related products.
  • US8268936B2
    申请人:——
    公开号:US8268936B2
    公开(公告)日:2012-09-18
查看更多